Enovis Corp (ENOV)
$46.56 -$0.33 (-0.70%) 4:37 PM 12/10/24
NYSE | $USD | Specialty Industrial MachineryStock Data
-
Market Cap
$2.66B -
Day's Range
$46.33 - $47.73 -
Volume
592,968 -
52 Week Low / High
$38.27 - $65.03 -
PE Ratio
- -
PEG Ratio
1.90 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 7
- Strong Buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $70.00
- Target Price
Company News
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says — Oct 3rd, 2024
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiated coverage on Enovis Corporation (NYSE:ENOV), a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
-
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th — Oct 10th, 2024
Enovis Corporation Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results o...
Portfolio
Comprised of 1 portfolios